1-3 of 3
John Desjarlais, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tuning T Cell Affinity Improves Efficacy and Safety of Anti-CD38 × Anti-CD3 Bispecific Antibodies in Monkeys - a Potential Therapy for Multiple Myeloma

Gregory L. Moore, PhD, Sung-Hyung Lee, PhD, Suzanne Schubbert, PhD, Yvonne Miranda, MS, Rumana Rashid, PhD, Erik Pong, BS, Sheryl Phung, MS, Emily W. Chan, BS, Hsing Chen, MS, Nancy Endo, BS, Maria C. Ardila, BS, Matthew J. Bernett, PhD, Seung Chu, PhD, Irene W.L. Leung, PhD, Umesh Muchhal, PhD, Christine Bonzon, PhD, David E Szymkowski, PhD, John Desjarlais, PhD
Journal: Blood
Blood (2015) 126 (23): 1798.
https://doi.org/10.1182/blood.V126.23.1798.1798
Published: 2015
Journal Articles

An Fc-Engineered Humanized Anti-CD40 Monoclonal Antibody, XmAb5485, Exhibits Potent Activity in Vitro and in Vivo against Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

Eugene A. Zhukovsky, PhD, Holly Horton, Ph.D, Matthias Peipp, PhD, Erik Pong, BS, Matthew Bernett, PhD, Sher Karki, PhD, John Richards, PhD, Seung Chu, PhD, Roland Repp, MD, John Desjarlais, PhD
Journal: Blood
Blood (2008) 112 (11): 881.
https://doi.org/10.1182/blood.V112.11.881.881
Published: 2008
Journal Articles

XmAb™ Fc Engineered Anti-CD19 Monoclonal Antibody with Enhanced In Vitro Efficacy Against Lymphoma and Leukemia.

Eugene Zhukovsky, PhD, Seung Chu, PhD, Matthew Bernett, PhD, Sher Karki, PhD, John Richards, PhD, Erik Pong, BS, Matthias Peipp, PhD, Roland Repp, MD, John Desjarlais, PhD
Journal: Blood
Blood (2007) 110 (11): 2335.
https://doi.org/10.1182/blood.V110.11.2335.2335
Published: 2007